Alzheimer's Disease Neuroimaging Initiative (ADNI4) — MICHAEL W WEINER (NORTHERN CALIFORNIA INSTITUTE/RES/EDU)
Overall: Summary/Abstract The overall goal of ADNI is to validate biomarkers for AD clinical trials. ADNI data is widely used for planning AD trials and use of ADNI data has enabled dramatic changes t
| Project title | Alzheimer's Disease Neuroimaging Initiative (ADNI4) |
|---|---|
| Project number | 2U19AG024904-16 |
| PI name | MICHAEL W WEINER |
| Institution | NORTHERN CALIFORNIA INSTITUTE/RES/EDU |
| Funding mechanism | U19 |
| Agency | NIA |
| Award amount | $30.39M |
| Fiscal year | 2022 |
| Project start | 2004-09-30T00:00:00 |
| Project end | 2027-07-31T00:00:00 |
| Abstract | Overall: Summary/Abstract The overall goal of ADNI is to validate biomarkers for AD clinical trials. ADNI data is widely used for planning AD trials and use of ADNI data has enabled dramatic changes t |
| Key terms | <AD dementia><AD model><AD prevention><Active Follow-up><Address><Aducanumab><Advertising><Advisory |
$799/mo
Try GrantRadar →